Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…
Emeraid Inc., a healthcare AI DX startup originating from the University of…
B-MAP Inc. is pleased to announce that it has today signed a…
Eisai and Shanghai Henlius Biotech have signed an exclusive commercialization agreement and…
Rakuten Medical, Inc., a biotech firm in the U.S., has partnered with…
Kura Oncology and Kyowa Kirin rolled out fresh data on KOMZIFTI ziftomenib…
Meiji Seika Pharma Co., Ltd. announced a strategic equity investment in Lyric…
Ubie Inc. is pleased to announce that, in collaboration with Kameda General…
Eisai and its global partner Biogen have filed a new drug application…
Emeraid Inc., a healthcare AI DX startup originating from the University of…
B-MAP Inc. is pleased to announce that it has today signed a…
Eisai and Shanghai Henlius Biotech have signed an exclusive commercialization agreement and…
Rakuten Medical, Inc., a biotech firm in the U.S., has partnered with…
Kura Oncology and Kyowa Kirin rolled out fresh data on KOMZIFTI ziftomenib…
Meiji Seika Pharma Co., Ltd. announced a strategic equity investment in Lyric…
Ubie Inc. is pleased to announce that, in collaboration with Kameda General…
Eisai and its global partner Biogen have filed a new drug application…
Sign in to your account